NLRP3 and neuropathy: In recent years, it has become apparent that neuroinflammatory processes mediate VIPN, and specifically, that vincristine leads to activation of the NLRP3 inflammasome in monocytes, which in turn affects the release of IL‐1β that drives neuropathy symptoms, such as sensory and motor disturbances.9